Subjects were divided into HC, NHIC, and HIC groups. Clinical Characteristics, urinary ultrasound parameters, and urinary biomarkers were collected for ML screening of predictive signatures. DEGs are identified from GEO transcriptomic data; scRNA‐seq delineates cell clusters, pseudotime trajectories and intercellular communication.
Cheng Luo +5 more
wiley +1 more source
Dextrose Prolotherapy's Impact on the Urinary Microbiome in Interstitial Cystitis/Bladder Pain Syndrome. [PDF]
Chen LK +7 more
europepmc +1 more source
Is Urethral Pain Syndrome Really Part of Bladder Pain Syndrome?
openaire +1 more source
S100A9 as a potential novel target for experimental autoimmune cystitis and interstitial cystitis/bladder pain syndrome. [PDF]
Zhao J +10 more
europepmc +1 more source
Comorbid bladder pain syndrome and vulvodynia - a cross-sectional analysis of the UNICORN-4 study. [PDF]
Okui N.
europepmc +1 more source
Long-Term Outcomes of Sacral Neuromodulation for Refractory Interstitial Cystitis/Bladder Pain Syndrome: A Retrospective Cohort Study. [PDF]
Rekatsina M +5 more
europepmc +1 more source
Correction to "Clinical Manifestations of Interstitial Cystitis and Bladder Pain Syndrome: Analysis of a Patient Registry in Japan". [PDF]
europepmc +1 more source
Matched serum- and urine-derived biomarkers of interstitial cystitis/bladder pain syndrome. [PDF]
Kuret T, Sterle I, Romih R, Veranič P.
europepmc +1 more source
Active Compounds, Targets, and Mechanisms of Salvia miltiorrhiza Bunge in Treating Interstitial Cystitis/Bladder Pain Syndrome. [PDF]
Wang L, Yu B, Wang Y, Qu X, Tang W.
europepmc +1 more source
2025 Canadian Urological Association Guideline: Selected treatment recommendations for interstitial cystitis/bladder pain syndrome. [PDF]
Doiron RC +7 more
europepmc +1 more source

